Melanoma‐derived factors alter the maturation and activation of differentiated tissue‐resident dendritic cells
- 16 June 2015
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 94 (1) , 24-38
Abstract
Dendritic cells (DCs) are key regulators of host immunity that are capable of inducing either immune tolerance or activation. In addition to their well‐characterized role in shaping immune responses to foreign pathogens, DCs are also known to be critical for the induction and maintenance of anti‐tumor immune responses. Therefore, it is important to understand how tumors influence the function of DCs and the quality of immune responses they elicit. Although the majority of studies in this field to date have utilized either immortalized DC lines or DC populations that have been generated under artificial conditions from hematopoietic precursors in vitro, we wished to investigate how tumors impact the function of already differentiated, tissue‐resident DCs. Therefore, we used both an ex vivo and in vivo model system to assess the influence of melanoma‐derived factors on DC maturation and activation. In ex vivo studies with freshly isolated splenic DCs, we demonstrate that the extent to which DC maturation and activation are altered by these factors correlates with melanoma tumorigenicity, and we identify partial roles for tumor‐derived transforming growth factor (TGF)β1 and vascular endothelial growth factor (VEGF)‐A in the altered functionality of DCs. In vivo studies using a lung metastasis model of melanoma also demonstrate tumorigenicity‐dependent alterations to the function of lung‐resident DCs, and skewed production of proinflammatory cytokines and chemokines by these tumor‐altered cells is associated with recruitment of an immune infiltrate that may ultimately favor tumor immune escape and outgrowth.Keywords
Funding Information
- Virginia's Commonwealth Health Research Board
- Virginia Academy of Science Jeffress Research
- Virginia Foundation
- Independent Colleges Undergraduate Science Research Fellowship
- Sigma Xi Grants-in-Aid of Research
This publication has 62 references indexed in Scilit:
- Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor ImmunityFrontiers in Immunology, 2013
- MELANOMA-ASSOCIATED SUPPRESSION OF THE DENDRITIC CELL LINES DC2.4 AND JAWSIIAmerican Journal of Immunology, 2012
- Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer CellsPLOS ONE, 2012
- Ovarian cancer progression is controlled by phenotypic changes in dendritic cellsJournal of Experimental Medicine, 2012
- Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal CancerPLOS ONE, 2011
- Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian CancerThe Journal of Immunology, 2011
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Induction of myeloid‐derived suppressor cells by tumor exosomesInternational Journal of Cancer, 2009
- Differential Response of Respiratory Dendritic Cell Subsets to Influenza Virus InfectionJournal of Virology, 2008
- Strategies and challenges in eliciting immunity to melanomaImmunological Reviews, 2008